Articles From: Textron AirLand’s Scorpion Makes Final Preparations for First Flight to Europe to TGI -- CitiScooter With Phone App


Textron AirLand, LLC, a joint venture between Textron Inc. (NYSE: TXT) and AirLand Enterprises, LLC, has announced that its Scorpion aircraft is progressing on schedule toward a July departure from McConnell Air Force Base in Kansas.
Sign-up for Textron AirLand’s Scorpion Makes Final Preparations for First Flight to Europe investment picks
The Board of Directors of Textron Inc. (NYSE:TXT) today declared a quarterly dividend of $0.02 per share on the company’s Common Stock.
Sign-up for Textron Declares Quarterly Dividend investment picks
Textron Inc. (NYSE: TXT) today reported second quarter 2014 income from continuing operations of $0.51 per share, up 27.5 percent from $0.40 per share in the second quarter of 2013.
Sign-up for Textron Reports Second Quarter 2014 Income from Continuing Operations of $0.51 per Share, up 27.5%; Revenues up 23.5% investment picks
Textura joins leading companies to discuss private-sector initiative to expedite payment to small suppliers CHICAGO , July 11, 2014 /PRNewswire/ -- Textura Corporation (NYSE: TXTR) , the leading provider of collaboration solutions for the construction industry, announced today that Textura Chairman and Chief Executive Officer Patrick Allin joined executives from several other companies at the White House today to discuss SupplierPay, an initiative the Obama Administration is launching to help strengthen small businesses by increasing their working capital.
Sign-up for Textura Chairman & CEO Patrick Allin Participates in White House Discussion with President Obama on SupplierPay investment picks
CHICAGO , July 15, 2014 /PRNewswire/ --
Sign-up for Textura Corporation Announces Second Quarter 2014 Earnings Release Date and Conference Call investment picks
Textura Corporation Named Finalist for 2014 ITA CityLIGHTS Award Canada NewsWire The 15th Annual ITA CityLIGHTS program honors companies and individuals whose innovation and success drive growth in the technology industry and Illinois CHICAGO , Aug.
Sign-up for Textura Corporation Named Finalist for 2014 ITA CityLIGHTS Award investment picks
The 15th Annual ITA CityLIGHTS program honors companies and individuals whose innovation and success drive growth in the technology industry and Illinois CHICAGO , Aug.
Sign-up for Textura Corporation Named Finalist for 2014 ITA CityLIGHTS Award investment picks
CHICAGO , July 22, 2014 /PRNewswire/ -- Textura Corporation (NYSE: TXTR) , the leading provider of collaboration solutions for the construction industry, announced today that it has been named one of Chicago's top job creators by Crain's Chicago Business magazine.
Sign-up for Textura Corporation Named One of Chicago's Top Job Creators by Crain's Chicago Business investment picks
2014/7/21
Annual list recognizes most influential construction technology providers.
Sign-up for Textura Corporation Named One of the Constructech 50 investment picks
2014/7/8
Well-known construction technology leader opening Textura office in London.
Sign-up for Textura Launches in the UK and Europe -- Colin Smith to Lead Operations investment picks
2014/7/17
Collaborative Solution Helps Subcontractors in New York, New Jersey and Connecticut Improve Efficiency and Enhance Productivity.
Sign-up for Textura-CPM is the Standard for Subcontractors in the Tri-State Area investment picks
NEWTOWN, Pa., July 29, 2014 (GLOBE NEWSWIRE) -- TF Financial Corporation (the "Company") (Nasdaq:THRD) today reported net income of $585,000 ($0.19 per diluted share) for the second quarter of 2014, compared with $1,381,000 ($0.45 per share) for the first quarter of 2014.
Sign-up for TF Financial Corporation Reports Second Quarter 2014 Results and Quarterly Dividend investment picks
CLEVELAND, July 11, 2014 (GLOBE NEWSWIRE) -- TFS Financial Corporation (Nasdaq:TFSL) (the "Company"), the holding company for Third Federal Savings and Loan Association of Cleveland, will report its financial results for three and nine month periods ending June 30, 2014, on Wednesday, July 30, 2014, after 4:00 p.m. Eastern Time.
Sign-up for TFS Financial Corporation Announces Fiscal Quarter Ended June 30, 2014 Financial Results Conference Call investment picks
CLEVELAND, July 30, 2014 (GLOBE NEWSWIRE) -- TFS Financial Corporation (Nasdaq:TFSL) (the "Company"), the holding company for Third Federal Savings and Loan Association of Cleveland (the "Association"), today announced results for the three and nine month periods ended June 30, 2014.
Sign-up for TFS Financial Corporation Announces Quarterly Earnings investment picks
CLEVELAND, Sept.
Sign-up for TFS Financial Corporation Announces Sixth Stock Repurchase Program investment picks
CLEVELAND, Aug.
Sign-up for TFS Financial Corporation Declares Dividend investment picks
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval Safety and Efficacy Data from Over 30 CLL Patients from the On-going Phase 2 Trial of the Combination of TG-1101 plus ibrutinib Anticipated to be Presented at ASH 2014 NEW YORK, Sept.
Sign-up for TG Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA for Its First Phase 3 Clinical Trial of TG-1101 (ublituximab) in Combination With Imbruvica(R) (ibrutinib) for Patients With Previously Treated Chronic Lymphocytic Leukemia investment picks
NEW YORK, June 24, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) , announced today an agreement with Ligand Pharmaceuticals Incorporated (Nasdaq:LGND) to license exclusive global rights to develop and commercialize Ligand's IRAK4 inhibitor research program.
Sign-up for TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4 investment picks
Investor Conference Call to be held July 22, 2014 at 8:30am EDT to discuss Second Quarter Financial Results and Preliminary Clinical Data Presented at The Pan Pacific Lymphoma Conference announced earlier today NEW YORK, July 21, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) , an innovative clinical-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for cancer and autoimmune diseases, today announced its results for the second quarter ended June 30, 2014 and recent company developments.
Sign-up for TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update investment picks
NEW YORK, June 23, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) , an innovative, clinical-stage biopharmaceutical company today announced that Michael Weiss, the Company's Interim Chief Executive Officer, will be presenting at the 2014 JMP Securities Healthcare Conference being held at the Westin New York Grand Central Hotel.
Sign-up for TG Therapeutics, Inc. to Present at the 2014 JMP Securities Healthcare Conference investment picks
NEW YORK, June 16, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) , an innovative, clinical-stage biopharmaceutical company today announced that Michael Weiss, the Company's Interim Chief Executive Officer, will be presenting at the 2014 Wells Fargo Healthcare Conference being held at the Intercontinental Hotel in Boston, Massachusetts.
Sign-up for TG Therapeutics, Inc. to Present at the 2014 Wells Fargo Healthcare Conference investment picks
100% of CLL/SLL patients had significant nodal reduction with either a normalization of or ≥80% reduction in Blood Lymphocyte Count 4 of 5 CLL/SLL patients achieved a partial response at first assessment, including a patient relapsed from a prior BTK-inhibitor, and the 5 th patient with stable disease achieved a 44% nodal reduction pending next assessment 2 of 5 heavily pretreated DLBCL patients achieved a PR, including one patient with GCB subtype refractory to prior therapy Combination appears well tolerated with no dose-related increases in toxicity observed among patients treated to date NEW YORK, July 21, 2014 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (Nasdaq:TGTX) , an innovative, clinical-stage biopharmaceutical company, today announced preliminary clinical results from its ongoing Phase I study of TG-1101 (ublituximab), the Company's novel glycoengineered anti-CD20 monoclonal antibody in combination with TGR-1202, the Company's novel,
Sign-up for TG Therapeutics' Novel Combination of TG-1101 (Ublituximab) and TGR-1202 Demonstrates Compelling Early Activity and Safety Profile in Patients With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) and Aggressive Lymphomas investment picks
PLANO, Texas , Aug.
Sign-up for TGC Industries Announces Purchase of Additional Wireless Recording Equipment investment picks
PLANO, Texas , July 1, 2014 /PRNewswire/ -- TGC Industries, Inc. (NASDAQ: TGE) today announced plans to release its second quarter 2014 financial results on Monday, July 28, 2014 before the market opens.
Sign-up for TGC Industries Announces Second Quarter 2014 Earnings Release and Conference Call Schedule investment picks
PLANO, Texas , July 1, 2014 /PRNewswire/ -- TGC Industries, Inc. (NASDAQ: TGE) today announced plans to release its second quarter 2014 financial results on Monday, July 28, 2014 before the market opens.
Sign-up for TGC Industries Announces Second Quarter 2014 Earnings Release and Conference Call Schedule investment picks
PLANO, Texas , July 28, 2014 /PRNewswire/ -- TGC Industries, Inc. (NASDAQ: TGE) ("TGC") today announced financial results for its second quarter ended June 30 , 2014.
Sign-up for TGC Industries Reports Second Quarter 2014 Results investment picks
2014/9/3
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G021001-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/9/3/11G021001/TGI_Solar_Power_Group_Inc.-1377521891703.jpg BROOKLYN, NY--(Marketwired - September 03, 2014) - TGI SOLAR POWER GROUP INC.
Sign-up for TGI -- CitiScooter With Phone App investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Textron AirLand’s Scorpion Makes Final Preparations for First Flight to Europe to TGI -- CitiScooter With Phone App
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices